Ridgefield, CT, United States of America

John Parkinson

This inventor holds 1 USPTO granted patent. Top assignees: Beth Israel Deaconess Medical Center, Inc., Thetis Pharmaceuticals LLC. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Parkinson. Retrieved from https://idiyas.com/inventor/john-parkinson-cp1lnd8f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: John Parkinson: Innovator in Cancer Therapy

Introduction

John Parkinson is a notable inventor based in Ridgefield, CT (US). He has made significant contributions to the field of cancer therapy through his innovative research and development. His work focuses on the use of resolvins in treating cancer, showcasing his commitment to advancing medical science.

Latest Patents

John Parkinson holds a patent for "Compositions and methods for cancer therapy." This invention relates to compositions comprising resolvins and their application in methods of treating cancer. His patent represents a crucial step forward in the fight against this devastating disease. He has 1 patent to his name.

Career Highlights

Throughout his career, John has worked with prominent organizations, including Thetis Pharmaceuticals LLC and Beth Israel Deaconess Medical Center, Inc. These experiences have allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

John has collaborated with esteemed colleagues such as Gary Mathias and Dipak Panigrahy. Their combined expertise has furthered the development of innovative cancer therapies.

Conclusion

John Parkinson's work in cancer therapy exemplifies the impact of innovation in medicine. His dedication to research and collaboration continues to inspire advancements in the treatment of cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…